| Receipt no. | First name | Last name | Abstract title |
|---|
| 10135 | Masayoshi | Yamamoto | Effect of Dipeptidyl Peptidase-4 Inhibitor on Cardiovascular Outcomes in Japanese Patients with Type 2 Diabetes and Heart Failure |
| 10198 | Shunsuke | Kiuchi | Addition of Azelnidipine to Standard Heart Failure Therapy Improves Cardiac Sympathetic Function in Patients with Hypertensive Heart Failure |
| 10483 | Meihua | Li | Central Donepezil Infusion Prevents Progression of Cardiac Remodeling and Improves Long-term Survival in Chronic Heart Failure Rats with Myocardial Infarction |
| 10492 | Yuji | Nagatomo | Anemia is Associated with Blunted Response to Carvedilol Therapy: Japanese Chronic Heart Failure (J-CHF) Study |
| 10537 | Akihiro | Nakagomi | Effects of Febuxostat and Allopurinol on the Inflammation and Cardiac Function in Chronic Heart Failure Patients with Hyperuricemia |
| 10616 | Naoto | Kawamatsu | Continuous Tolvaptan Treatment Improves Clinical Outcomes in Patients with Well-Controled Right-Sided Heart Congestion at Discharge. |
| 10622 | Hidekatsu | Fukuta | The Effect of Statins on Mortality in Heart Failure with Preserved Ejection Fraction: A Meta-Analysis of Propensity Score Analyses |
| 10691 | Keiichi | Kohashi | Impacts of Dipeptidyl Peptide-4 Inhibitors on the Inflammation, Cardiac Function and Long-term Prognosis of Chronic Heart Failure Patients with Diabetes |
| 10771 | Makito | Sato | High-dose Carvedilol Therapy Improves Sympathetic Nerve Activity than Low-dose Therapy in Patients with Nonischemic Chronic Heart Failure |
| 11063 | Koichiro | Kinugawa | Who needs longer treatment of tolvaptan? -An interim analysis from the Samsca post-Marketing surveillance In heart faiLurE (SMILE study)- |
| 11217 | Shunsuke | Kuroda | Effectiveness of Intravenous Amiodarone for Patients with Atrial Fibrillation and Acute Decompensated Heart Failure |
| 11223 | Soichiro | Aoki | Reduced Response for Loop Diuretics with Volume Retention Predicts Future Cardiac Events in Acute Decompensated Heart Failure Patients |
| 11237 | Wataru | Takahashi | Influences of Renal Dysfunction to the Clinical Effects of Carvedilol in Patients with Chronic Systolic Heart Failure |
| 11304 | Keisuke | Kida | Efficacy of Add-on Tolvaptan to Furosemide Versus Increased Furosemide Treatment on Heart Failure with Advanced Kidney Dysfunction:From the K-STAR Study |
| 11461 | Shintarou | Dobashi | Comparative Effects of Milrinone and Olprinone in Patients with Congestive Heart Failure |
| 11506 | Takayuki | Sekihara | An Echocardiographic Finding of Right Ventricular Overload is a Predictor of an Acute Increase in Urine Output Due to Tolvaptan |
| 11525 | Masaki | Kinoshita | The effects of tolvaptan on acute decompensated heart failure patients with chronic kidney disease. |
| 11672 | Ryuichi | Ushijima | Protective Effect of Low Dose of Beta-blockers on Worsening of Renal Function in Heart Failure Patients with Sympathetic Overactivation |
| 11769 | Koichiro | Sugimura | Prognostic Effect of Diuretics for Japanese Patients with Chronic Heart Failure-A Report from the CHART-2 Study- |
| 12216 | Naotaka | Okamoto | Risk factors for worsening renal failure in adding tolvaptan to conventional therapy for patient with severe decompensated heart failure |
| 12324 | Toshiaki | Isogai | Effect of calcium channel blockers on long-term prognosis in heart failure patients with beta-blockers and renin-angiotensin system blockades: propensity-score analysis |
| 12413 | Shogo | Oishi | Clincal Aspects of Continuous Intravenous Morphine for Palliative Care in Patients with Advanced Heart Failure from Experience with 50 Cases |
| 12524 | Shiro | Ishihara | Comparable Effects of Vasodilators and Inotropes on hemodynamic Congestion: Systematic Review and Meta-Analysis of Hemodynamic Studies of Acute Heart Failure |
| 12531 | Hiroyuki | Shimoura | Effects of a Change-Over from Other Angiotensin II Receptor Blockers to Olmesartan on Left Ventricular Hypertrophy in Heart Failure Patients |
| 12638 | Masanobu | Miura | Prognostic Impacts of Supplemental Use of Angiotensin Receptor Blocker Olmesartan with a Special Reference to Left Ventricular Ejection Fraction |
| 12798 | Yoichi | Takaya | Conflicting Effects of Carperitide between Acute kidney Injury (AKI) and Mortality in Patients with Acute Decompensated Heart Failure (ADHF) |
| 12799 | Yuko | Soyama | The Effectiveness of Chronic Beta Blockade on Diastolic Function in HFrEF and HFpEF |
| 12897 | Yusuke | Nakano | Impact of Continuous Use of Tolvaptan for Renal Function in Patients with Heart Failure |
| 12980 | Akiyo | Eguchi | Tolvaptan Alone Significantly Worsend Myocardial Remodeling and Survival via Increase of the Aquaporin 1 in Kidney in Murine Heart Failure |
| 13024 | Taiki | Kinjo | β-Blocker Usage in Symptomatic Heart Failure Patients with Reduced Ejection Fraction and Atrial Fibrillation: Analysis from Shinken Database 2004-2013 |
| 13072 | Haruya | Kawase | Pressure overload induces abnormal shortage of circulating glucagon-like peptide-1 thereby enhances myocardial apoptosis via the EPAC1/Bcl2 axis |
| 13289 | Michitaka | Amioka | Development of atrial fibrillation is a bad sign during anthracycline chemotherapy |
| 13458 | Kenichi | Hiasa | FEK-guided-administration of tolvaptan may improve survival rate via minimization of excessive intravascular volume reduction |
| 13493 | Noboru | Oda | The experience of palliative use of morphine for the patients with terminal cardiovascular disease. |
| 13512 | Yuki | Ikeda | Different Factors for Predicting Diuretic Response in Heart Failure Patients with Renal Impairment: a Randomized Study Comparing Tolvaptan and Furosemide |
| 13561 | Yasuhiro | Ikeda | Identification of Factors Affecting Readmission of Heart Failure in Patients Over 75 Years of Age. |
| 13629 | Dai | Okayama | Adverse Outcomes of High Dose Loop Diuretic Use in Tolvaptan Responder with Heart Failure |
| 13800 | Kazuhiro | Kimura | Early Administration of Tolvaptan Achieves Early Decongestion in Elderly Patients with Acute Decompensated Heart Failure |
| 13821 | Tatsuaki | Murakami | A SGLT2 Inhibitor Early Reverses Metabolic and Cardiac Dysfunction in Type-2 Diabetics with Chronic Heart Failure |
| 20044 | Tuo | Liang | Cardio protection effect of Qiliqiangxin capsule on left ventricular remodeling, dysfunction in heart failure rat through activating Akt/VEGF pathway |
